Cumberland Pharmaceuticals (CPIX) Cash & Equivalents Growth (1y) (2011 - 2026)
Cumberland Pharmaceuticals (CPIX) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 69.13% |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 2.86% |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 19.56% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 13.19% |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | 56.51% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 25.91% |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | -1.67% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | -4.65% |
| 10 | Cumberland Pharmaceuticals | 117.61 Mn | 113.74 Mn | - | -75.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -75.99% |
| Mar 31, 2026 | -27.14% |
| Dec 31, 2025 | -36.29% |
| Sep 30, 2025 | -12.99% |
| Jun 30, 2025 | -7.21% |
| Mar 31, 2025 | -18.55% |
| Dec 31, 2024 | -1.95% |
| Sep 30, 2024 | -5.64% |
| Jun 30, 2024 | -5.00% |
| Mar 31, 2024 | 13.20% |
| Dec 31, 2023 | -7.27% |
| Sep 30, 2023 | -5.29% |
| Jun 30, 2023 | 0.18% |
| Mar 31, 2023 | -5.10% |
| Dec 31, 2022 | -26.93% |
| Sep 30, 2022 | -24.38% |
| Jun 30, 2022 | -29.04% |
| Mar 31, 2022 | -30.72% |
| Dec 31, 2021 | 9.24% |
| Sep 30, 2021 | -3.01% |